Binh Dinh Pharmaceutical & Medical Equipment JSC

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: VN000000DBD0
VND
54,400.00
600 (1.12%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Poor long term growth as Net Sales has grown by an annual rate of 6.75% over the last 5 years

 
2

Flat results in Dec 25

3

With ROE of 18.73%, it has a fair valuation with a 3.07 Price to Book Value

4

Below par performance in long term as well as near term

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

VND 4,913,442 Million (Small Cap)

stock-summary
P/E

16.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

3.05%

stock-summary
Debt Equity

-0.27

stock-summary
Return on Equity

17.08%

stock-summary
Price to Book

2.87

Revenue and Profits:
Net Sales:
509,952 Million
(Quarterly Results - Dec 2025)
Net Profit:
59,493 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-4.9%
0%
-4.9%
6 Months
-9.18%
0%
-9.18%
1 Year
27.34%
0%
27.34%
2 Years
41.23%
0%
41.23%
3 Years
45.61%
0%
45.61%
4 Years
111.85%
0%
111.85%
5 Years
102.58%
0%
102.58%

Binh Dinh Pharmaceutical & Medical Equipment JSC for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
6.75%
EBIT Growth (5y)
12.83%
EBIT to Interest (avg)
70.23
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.21
Sales to Capital Employed (avg)
1.07
Tax Ratio
15.36%
Dividend Payout Ratio
79.06%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
22.57%
ROE (avg)
17.11%

Valuation key factors

Factor
Value
P/E Ratio
16
Industry P/E
Price to Book Value
3.07
EV to EBIT
13.70
EV to EBITDA
11.92
EV to Capital Employed
3.84
EV to Sales
2.50
PEG Ratio
NA
Dividend Yield
2.98%
ROCE (Latest)
28.06%
ROE (Latest)
18.73%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
No Trend
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 15.98% vs -7.34% in Sep 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -0.69% vs -33.68% in Sep 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "509,951.70",
          "val2": "439,698.40",
          "chgp": "15.98%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "71,108.10",
          "val2": "88,463.30",
          "chgp": "-19.62%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1,002.00",
          "val2": "1,340.00",
          "chgp": "-25.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "59,493.10",
          "val2": "59,909.00",
          "chgp": "-0.69%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "114.60%",
          "val2": "172.00%",
          "chgp": "-5.74%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 7.97% vs 4.59% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 22.86% vs 2.28% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,865,232.20",
          "val2": "1,727,548.40",
          "chgp": "7.97%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "375,720.90",
          "val2": "353,704.60",
          "chgp": "6.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3,846.60",
          "val2": "4,058.10",
          "chgp": "-5.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "290,747.90",
          "val2": "236,656.50",
          "chgp": "22.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "174.10%",
          "val2": "176.90%",
          "chgp": "-0.28%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQstock-summary

Dec'25
Sep'25
Change(%)
Net Sales
509,951.70
439,698.40
15.98%
Operating Profit (PBDIT) excl Other Income
71,108.10
88,463.30
-19.62%
Interest
1,002.00
1,340.00
-25.22%
Exceptional Items
0.00
0.00
Consolidate Net Profit
59,493.10
59,909.00
-0.69%
Operating Profit Margin (Excl OI)
114.60%
172.00%
-5.74%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2025 is 15.98% vs -7.34% in Sep 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is -0.69% vs -33.68% in Sep 2025

Annual Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
1,865,232.20
1,727,548.40
7.97%
Operating Profit (PBDIT) excl Other Income
375,720.90
353,704.60
6.22%
Interest
3,846.60
4,058.10
-5.21%
Exceptional Items
0.00
0.00
Consolidate Net Profit
290,747.90
236,656.50
22.86%
Operating Profit Margin (Excl OI)
174.10%
176.90%
-0.28%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2025 is 7.97% vs 4.59% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 22.86% vs 2.28% in Dec 2024

stock-summaryCompany CV
About Binh Dinh Pharmaceutical & Medical Equipment JSC stock-summary
stock-summary
Binh Dinh Pharmaceutical & Medical Equipment JSC
Pharmaceuticals & Biotechnology
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company (Bidiphar) is a Vietnam-based company primarily engaged in pharmaceuticals sector. The Company's leading business activities are the production and wholesale of medicines, including antibiotics, antipyretics, pain relievers, cardiovascular drugs, antifungal and antiviral drugs, respiratory drugs, vitamins and functional food, among others. Bidiphar is also involved in the manufacture and distribution of medical equipment, supplies and packaging.
Company Coordinates stock-summary
Company Details
498 Nguyen Thai Hoc, Phuong Quang Trung , QUI NHON None : None
stock-summary
Tel: 84 25 63846500
stock-summary
Registrar Details